These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29150318)

  • 1. Postsurgical Management of Differentiated Thyroid Cancer in China.
    Wei WJ; Zhang GQ; Luo QY
    Trends Endocrinol Metab; 2018 Feb; 29(2):71-73. PubMed ID: 29150318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controversies in the follow-up and management of well-differentiated thyroid cancer. New answers to old questions].
    Abós Olivares MD; Pesquera González C
    Rev Esp Med Nucl; 2005; 24(3):207-15. PubMed ID: 15847791
    [No Abstract]   [Full Text] [Related]  

  • 4. [The early treatment results of well differentiated thyroid cancer and its dependence on chosen factors].
    Kłubo-Gwieździńska J; Junik R
    Endokrynol Pol; 2008; 59(2):123-30. PubMed ID: 18465687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.
    Mazzaferri EL; Kloos RT
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1447-63. PubMed ID: 11297567
    [No Abstract]   [Full Text] [Related]  

  • 6. Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy.
    San Román Gil M; Pozas J; Molina-Cerrillo J; Gómez J; Pian H; Pozas M; Carrato A; Grande E; Alonso-Gordoa T
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Poorly differentiated thyroid carcinomas: new therapeutic considerations].
    Graf H
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):711-8. PubMed ID: 16444353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current state of the treatment of thyroid cancer].
    Paches AI; Liubaev VL; Shental' VV; Pustynskiĭ IN; Abdullin NA
    Vopr Onkol; 1998; 44(5):562-6. PubMed ID: 9884715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiated Thyroid Cancer-Treatment: State of the Art.
    Schmidbauer B; Menhart K; Hellwig D; Grosse J
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclides and therapy of thyroid cancer.
    O'Doherty MJ; Nunan TO; Croft DN
    Nucl Med Commun; 1993 Sep; 14(9):736-55. PubMed ID: 8233239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of thyroid cancer: 2007--a basic review.
    Randolph GW; Thompson GB; Branovan DI; Tuttle RM
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S92-7. PubMed ID: 17848306
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of differentiated carcinoma of the thyroid gland].
    Mimura T; Ito K
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1184-9. PubMed ID: 9379097
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions.
    Dadu R; Cabanillas ME
    Minerva Endocrinol; 2012 Dec; 37(4):335-56. PubMed ID: 23235190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy.
    Turner N; Hamidi S; Ouni R; Rico R; Henderson YC; Puche M; Alekseev S; Colunga-Minutti JG; Zafereo ME; Lai SY; Kim ST; Cabanillas ME; Nurieva R
    Front Immunol; 2024; 15():1369780. PubMed ID: 38868771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of metastatic differentiated thyroid carcinoma.
    Sherman SI
    Rev Endocr Metab Disord; 2000 Apr; 1(3):165-71. PubMed ID: 11705002
    [No Abstract]   [Full Text] [Related]  

  • 16. Postsurgical management of differentiated thyroid carcinoma.
    Mazzaferri EL; Robyn J
    Otolaryngol Clin North Am; 1996 Aug; 29(4):637-62. PubMed ID: 8844735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].
    Mäenpää H
    Duodecim; 2014; 130(6):573-9. PubMed ID: 24724456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012.
    Carhill AA; Litofsky DR; Ross DS; Jonklaas J; Cooper DS; Brierley JD; Ladenson PW; Ain KB; Fein HG; Haugen BR; Magner J; Skarulis MC; Steward DL; Xing M; Maxon HR; Sherman SI
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3270-9. PubMed ID: 26171797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.
    Lamartina L; Durante C; Lucisano G; Grani G; Bellantone R; Lombardi CP; Pontecorvi A; Arvat E; Felicetti F; Zatelli MC; Rossi R; Puxeddu E; Morelli S; Torlontano M; Crocetti U; Montesano T; Giubbini R; Orlandi F; Aimaretti G; Monzani F; Attard M; Francese C; Antonelli A; Limone P; Rossetto R; Fugazzola L; Meringolo D; Bruno R; Tumino S; Ceresini G; Centanni M; Monti S; Salvatore D; Spiazzi G; Mian C; Persani L; Barbaro D; Nicolucci A; Filetti S
    Thyroid; 2017 Dec; 27(12):1490-1497. PubMed ID: 29020892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
    Pacini F; Schlumberger M; Dralle H; Elisei R; Smit JW; Wiersinga W;
    Eur J Endocrinol; 2006 Jun; 154(6):787-803. PubMed ID: 16728537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.